<ѻý>Entresto Boosts Sex in HF; Venom Antidote to Xa Drugs; Guilty Plea for FH Vaguenessѻý> Recent developments of interest in cardiovascular medicine Sep 25, 2017
<ѻý>HF Monitor Trips on PA Injury in Postmarket Surveillanceѻý> Reintervention or device recalibration often needed after PA injury Sep 18, 2017
<ѻý>TTR Cardiomyopathy Easily Detected By Biceps Bunchingѻý> Biceps tendon rupture may be a clue to HF cause Sep 12, 2017
<ѻý>ESC: Merck REVEALS a Slightly Positive CETP Inhibitor Trialѻý> A CETP inhibitor scores after 3 strikes for the class Aug 29, 2017
<ѻý>Inflammation, Secondary Prevention, Diet in Spotlight at ESCѻý> CANTOS, COMPASS, PURE will headline the world's largest cardiology meeting Aug 24, 2017
<ѻý>Guidance Issued on PET Imaging in Diagnosing Cardiac Sarcoidosisѻý> ASNC, SNMMI release recommendations for difficult diagnostic challenge Aug 19, 2017
<ѻý>Studies Stop Short of Quelling TAVR Durability Fearsѻý> Structural valve deterioration observed in 3.9% over 5 years May 20, 2017
<ѻý>Does Longer TAVR Time Make Stroke More Likely?ѻý> SURTAVI neuro substudy bolsters comparability between TAVR, SAVR May 19, 2017
<ѻý>Lotus TAVR Device Again Trips Up on Pacemaker Rateѻý> Otherwise, efficacy superior overall against CoreValve in REPRISE III trial May 17, 2017
<ѻý>As Hospital TAVR Volume Goes Up, Readmits Go Downѻý> Is it time for TAVR regionalization? May 14, 2017
<ѻý>Lower BP Targeted in New Heart Failure Guidelinesѻý> ACC/AHA/HFSA recommend adjusted SPRINT target of May 02, 2017
<ѻý>CardioBrief: Serious Questions Raised About Validity Of International Trialsѻý> TOPCAT analysis is the 'smoking gun' for trouble from 'offshoring' trials Apr 26, 2017
<ѻý>Best (Musical) Beats for CPR Training (CNN)ѻý> Synchrony with CPR components essential Mar 21, 2017
<ѻý>Dosing Crucial for Digoxin, Warfarin Safetyѻý> Digoxin unsafe at high levels regardless of heart failure Mar 21, 2017
<ѻý>SURTAVI: TAVR Matches Surgery in Lowest-Risk Cohortѻý> But reinterventions, parvalvular regurgitation, and pacemaker implants mar a supposed victory Mar 17, 2017
<ѻý>Everyday Exposure to EM Fields Can Disrupt Pacemakersѻý> Lower sensitivity and bipolar sensing recommended Feb 27, 2017
<ѻý>Wise Buy? Left Ventricular Assist Devicesѻý> Getting better and cheaper, but 'nobody wears pink ribbons for heart failure' Feb 21, 2017
<ѻý>Subclavian TAVR Safe When Femoral Access Is Riskyѻý> Trial analysis shows similar morbidity, mortality Jan 24, 2017
<ѻý>SAVR Beats Expectations in Intermediate Risk Trialѻý> Lower mortality than surgical risk score predicted in PARTNER 2A Jan 24, 2017
<ѻý>Novartis Pulls Out of Controversial Entresto Contestѻý> Cardiologists named to review panel had quit Dec 19, 2016
<ѻý>CMS to Offer Billing Code for Heart Failure Specialistsѻý> Should eliminate denials for appearance of double-billing Dec 02, 2016
<ѻý>Trial: No Benefit for High-Dose Diuretic in Acute HFѻý> But phase II results might not be the final word Nov 17, 2016
<ѻý>AHA: No Pump Thrombosis With Next-Gen LVAD?ѻý> Better outcomes in HeartMate 3 trial hinged on fewer malfunctions Nov 16, 2016
<ѻý>AHA: Real World TAVR Is All About Patient Selectionѻý> Intermediate risk is a moving target Nov 15, 2016
<ѻý>AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilatorѻý> Investigational drug ularitide had no effect on mortality or clinical outcomes Nov 13, 2016
<ѻý>TCT: TAVR Holds Up Pretty Well Over Timeѻý> Also, 2-year data confirm lasting improvements in QoL Nov 02, 2016
<ѻý>TCT: Embolic Protection Flops for TAVRѻý> New brain lesions or clinical strokes unaffected in SENTINEL trial Nov 01, 2016
<ѻý>CardioBrief: Impella No Better Than IABP in Cardiogenic Shockѻý> Underpowered IMPRESS trial shows no mortality benefit Oct 30, 2016
<ѻý>HFSA: Clinical Benefits Tied To Lung Monitoring Persistѻý> HF rehospitalization, deaths remain reduced up to 4.5 years Sep 21, 2016
<ѻý>Cardiac Myosin Activator Shows Promise for LV Functionѻý> 'More hands pulling on the rope' Sep 21, 2016
<ѻý>HFSA: Treat to NT-proBNP Target Flops in Trialѻý> Outcomes no better with treatment aimed at 30% reduction Sep 20, 2016
<ѻý>HFSA: Did LAP Monitoring Cut HF Rehospitalizations?ѻý> LAPTOP-HF investigators tried to make sense of terminated study Sep 19, 2016
<ѻý>ESC: No Mortality Benefit With ICD in Nonischemic HFѻý> Eleven fewer deaths over 5 years Aug 28, 2016
<ѻý>Stores' Security Systems Can Mess With Cardiac Devicesѻý> ICD, pacemaker hiccups seen near anti-shoplifting monitors in lab study Jun 10, 2016
<ѻý>Survival Rates Good With VAD for Complicated Acute MIѻý> Despite being sicker to start, outcomes on par with other VAD patients Apr 18, 2016
<ѻý>Podcast: 10th Anniversary for HealthNewsReview.orgѻý> Gary Schwitzer reflects on high points, low points, lessons learned Apr 14, 2016
<ѻý>ACC: After a Decade, CABG Pulls Ahead of Meds for HFѻý> Life-saving benefit of CABG now clear in long-term trial follow-up Apr 04, 2016
<ѻý>Entresto: Why Is There Silence? We're Not Selling iPhonesѻý> The drug hailed as a true PARADIGM shift, is slow out of the gate Apr 04, 2016 video
<ѻý>ACC: TAVR Once Again Non-Inferior to Surgeryѻý> No excess stroke or mortality at 2 years in lowest risk trial population yet studied Apr 02, 2016
<ѻý>CardioBrief: Top HF Expert Decries 'Unbelievable Folly' of Clinical Trials and Guidelinesѻý> Milton Packer, MD, calls the system to test and evaluate heart failure drugs dysfunctional Mar 23, 2016